期刊文献+

10-羟基喜树碱对肝癌细胞HepG2 DNA甲基化水平的调节作用研究 被引量:2

Effects of 10-hydroxycamptothecine on the Regulation of DNA Methylation Level in Liver Cancer Cell Hep G2
原文传递
导出
摘要 目的:研究10-羟基喜树碱对肝癌细胞Hep G2的DNA甲基化水平的调节作用。方法:体外培养Hep G2细胞,分为给药组(10-羟基喜树碱25μg/ml)和空白对照组,每组6个小组,每小组5个平行孔,分别于给药后24、48、72 h各组取2个小组,一组用MTT法检测Hep G2细胞的生长抑制率;另一组提取Hep G2细胞的DNA,酸水解后高效液相色谱法检测其甲基化率。结果:10-羟基喜树碱作用24、48、72 h后,Hep G2细胞的生长抑制率分别为(61.6±4.9)%、(85.7±0.7)%、(97.9±0.7)%;给药组Hep G2细胞DNA甲基化率分别为(2.81±0.34)%、(6.67±0.24)%、(6.83±0.24)%,明显高于相应的空白对照组[(1.88±0.13)%、(1.91±0.11)%、(1.98±0.18)%](P<0.05),且与作用时间呈正相关。结论:10-羟基喜树碱在抑制Hep G2细胞的生长的同时提高了细胞DNA的甲基化水平。 OBJECTIVE: To study the effects of 10-hydroxycamptothecine (10-HCPT) on the regulation of DNA methylation level in liver cancer cell HepG2. METHODS: Liver cancer cell HepG2 was cultured in vitro and divided into medication group (10-HCPT 25 μg/ml) and blank control group with 6 subgroups in each group. There were 5 parallel holes in each subgroup. 2 sub- groups were sampled in each group 24, 48 and 72 h after medication. For one subgroup, the growth inhibition rates of HepG2 was detected by using MTT assay; for another subgroup, DNA of HepG2 and the parallel test cell were extracted respectively, and the methylation rate was determined by HPLC after acid hydrolysis. RESULTS: After treated with 10-HCPT for 24, 48 and 72 h, the growth inhibition rates of HepG2 were (61.6 ± 4.9)%, (85.7 ± 0.7)% and (97.9 ± 0.7)%. The DNA methylation rate of medication group were (2.81 ± 0.34)%, (6.67 ± 0.24)% and (6.83 ± 0.24)%, which were significantly higher than those of blank control group [(1.88 ± 0.13% ), (1.91± 0.11)% and (1.98± 0.18)%] (P〈0.05), positively associated with treatment time. CONCLUSIONS: 10-HCPT may increase the overall DNA methylation level during inhibiting cancer cell.
出处 《中国药房》 CAS CSCD 2014年第45期4245-4247,共3页 China Pharmacy
基金 湖南省教育厅科研项目(No.11C0943) 湖南省"十二五"中药学重点学科资助项目(No.湘教通〔2011〕76)
关键词 10-羟基喜树碱 甲基化 肝癌细胞Hep G2 抑癌机制 10-hydroxycamptothecine Methylation Liver cancer cell HepG2 Cancer inhibition mechanism
  • 相关文献

参考文献19

  • 1Nagai M, Nakamura A, Makina R, et al. Expression of DNA (5-cytosin) -methyltransferases (DNMTs) in hepa- to-cellular carcinomas[J]. Hepatol Res, 2003,26 ( 3 ) : 186.
  • 2邱烈.CpG岛甲基化异常的致癌作用[J].检验医学与临床,2007,4(8):746-748. 被引量:4
  • 3Ahmed IA, Pusch CM, Hamed T, et al. Epigenetic altera- tions by methylation of RASSF1A and DAPK1 promoter sequences in manmary carcinoma detected in extracellular tumor DNA[J]. Cancer Genet Cytogenet, 2010, 199 (2) : 96.
  • 4李培坤,耿小平,朱立新.DNA甲基化抑制剂研究进展[J].国际药学研究杂志,2010,37(3):198-202. 被引量:17
  • 5赵军,黄金路,赵国海.去甲基化药物治疗肿瘤新进展[J].生物技术通讯,2009,20(6):849-851. 被引量:2
  • 6汤绍辉,杨冬华.DNA低甲基化与肝细胞癌[J].临床内科杂志,2007,24(8):512-514. 被引量:1
  • 7李爽(综述),刘文天(审校).DNA低甲基化与胃癌发病的关系[J].国际肿瘤学杂志,2007,34(9):698-701. 被引量:5
  • 8Beier V, Mund C, Hoheisel JD. Monitoring methylation changes in cancer[J]. Adv Biochem Eng Biotechnol, 2007, 104(1):1.
  • 9Luo DY, Zhang BZ, Lv LB, et al. Methylation of CpG is- lands of p16 associated with progression of primary gas- tric carcinomas[J]. Lab Invest, 2006,86 (6) : 591.
  • 10Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases[J]. Biochim Biophys Acta, 2007, 1 775 (1):138.

二级参考文献120

共引文献65

同被引文献35

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部